{"id":141641,"date":"2021-11-16T09:02:51","date_gmt":"2021-11-16T13:02:51","guid":{"rendered":"https:\/\/antiguanewsroom.com\/?p=141641"},"modified":"2021-11-16T09:02:51","modified_gmt":"2021-11-16T13:02:51","slug":"autoimmune-disorder-warning-added-to-astrazeneca-jj-vaccines","status":"publish","type":"post","link":"https:\/\/antiguanewsroom.com\/autoimmune-disorder-warning-added-to-astrazeneca-jj-vaccines\/","title":{"rendered":"Autoimmune disorder warning added to AstraZeneca, J&J vaccines"},"content":{"rendered":"
\"\"<\/a><\/div>
\"\"<\/a><\/div>

Health Canada<\/a>\u00a0is updating the labels for the\u00a0AstraZeneca<\/a>\u00a0and Johnson & Johnson\u00a0COVID-19<\/a>\u00a0vaccines to add immune thrombocytopenia (ITP), an autoimmune condition, as a potential side effect.<\/p>

\"\"<\/a><\/div>\n

\"\"In a statement on Tuesday, the agency said very rare cases of ITP have been reported internationally after receiving the Vaxzevria (AstraZeneca) and Janssen (J&J) COVID-19 vaccines.<\/p>\n

<\/div>\n

ITP is a disorder that can cause easy or excessive bruising and bleeding, which results from unusually low blood platelet levels.<\/p>

\"\"<\/a><\/div>
\"\"<\/a><\/div>\n
<\/div>\n

Such cases typically occur within 28 days after vaccination, the agency said. Deaths as a result of post-vaccination ITP have been reported outside of Canada. Some cases occurred in individuals who had a prior history of the disorder.<\/p>

\"\"<\/a><\/div>\n
<\/div>\n

Both the AstraZeneca and J&J vaccines have been approved for use in Canada and are deemed safe and effective.<\/p>\n

The agency advised Canadians to seek immediate medical attention if any of the following symptoms occurred after receiving the AstraZeneca and J&J shots:<\/p>

\"\"<\/a><\/div>\n